Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionZions Bancorporation
Latest Disclosed Ownership3,206 shares
Latest Disclosed Value $ 558,000
Zions Bancorporation ownership in EW / Edwards Lifesciences Corporation

On November 2, 2018 - Zions Bancorporation filed a 13F-HR form disclosing ownership of 3,206 shares of Edwards Lifesciences Corporation (US:EW) valued at $186,055 USD as of September 30, 2018. The entity filed a previous 13F-HR on February 14, 2018 disclosing 0 shares of Edwards Lifesciences Corporation. The current value of the position is $275,588 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2018-11-02 2018-09-30 13F Edwards Lifesciences Com 28176E108 3,206 3,206 558 0.1328
2018-02-14 2017-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 0 -4,081 -100.00 0 -100.00
2017-11-14 2017-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,081 4,048 12,266.67 447 11,075.00 0.0644
2017-08-14 2017-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 33 -2 -5.71 4 0.00 0.0007
2017-05-17 2017-03-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 35 -71 -66.98 4 -60.00 0.0008
2017-05-15 2017-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 106 10
2017-02-14 2016-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 106 34 47.22 10 25.00 0.0018
2016-11-15 2016-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 72 -1 -1.37 8 0.00 0.0015
2016-08-15 2016-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 73 1 1.39 8 0.00 0.0014
2016-05-16 2016-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 72 -8 -10.00 8 14.29 0.0014
2016-02-16 2015-12-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 80 44 122.22 7 16.67 0.0012
2016-02-16 2015-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 80 7
2015-11-16 2015-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 36 36 0.00 6 0.0011
2015-08-13 2015-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 0 -43 -100.00 0 -100.00
2015-05-13 2015-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 43 43 7 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.